Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Apr;84(5):837-846.
doi: 10.1111/his.15127. Epub 2024 Jan 12.

Demographics and additional haematologic cancers of patients with histiocytic/dendritic cell neoplasms

Paul G Kemps  1   2 , Lennart Kester  2 , Marijn A Scheijde-Vermeulen  2 , Carel J M van Noesel  3 , Robert M Verdijk  1   4 , Arjan Diepstra  5 , Ariënne M W van Marion  6 , Natasja Dors  2 , Cor van den Bos  2 , Annette H Bruggink  7 , Pancras C W Hogendoorn  1 , Astrid G S van Halteren  1   2   8
Affiliations

Demographics and additional haematologic cancers of patients with histiocytic/dendritic cell neoplasms

Paul G Kemps et al. Histopathology. 2024 Apr.

Abstract

Aims: The discovery of somatic genetic alterations established many histiocytic disorders as haematologic neoplasms. We aimed to investigate the demographic characteristics and additional haematologic cancers of patients diagnosed with histiocytic disorders in The Netherlands.

Methods and results: We retrieved data on histiocytosis patients from the Dutch Nationwide Pathology Databank (Palga). During 1993 to 2022, more than 4000 patients with a pathologist-assigned diagnosis of a histiocytic disorder were registered in Palga. Xanthogranulomas were the most common subtype, challenging the prevailing assumption that Langerhans cell histiocytosis (LCH) is the most common histiocytic disorder. LCH and juvenile xanthogranuloma (JXG) had a peak incidence in the first years of life; males were overrepresented among all histiocytosis subgroups. 118 patients had a histiocytic disorder and an additional haematologic malignancy, including 107 (91%) adults at the time of histiocytosis diagnosis. In 16/118 patients, both entities had been analysed for the same genetic alteration(s). In 11 of these 16 patients, identical genetic alterations had been detected in both haematologic neoplasms. This included two patients with PAX5 p.P80R mutated B cell acute lymphoblastic leukaemia and secondary histiocytic sarcoma, further supporting that PAX5 alterations may predispose (precursor) B cells to differentiate into the myeloid lineage. All 4/11 patients with myeloid neoplasms as their additional haematologic malignancy had shared N/KRAS mutations.

Conclusions: This population-based study highlights the frequency of xanthogranulomas. Furthermore, our data add to the growing evidence supporting clonal relationships between histiocytic/dendritic cell neoplasms and additional myeloid or lymphoid malignancies. Particularly adult histiocytosis patients should be carefully evaluated for the development of these associated haematologic cancers.

Keywords: bone marrow diseases; bone neoplasms; demography; dendritic cells; histiocytosis; leukaemia; lymphoma.

PubMed Disclaimer

References

    1. Emile J-F, Abla O, Fraitag S et al. Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages. Blood 2016; 127; 2672-2681.
    1. Khoury JD, Solary E, Abla O et al. The 5th edition of the World Health Organization classification of haematolymphoid tumours: myeloid and histiocytic/dendritic neoplasms. Leukemia 2022; 36; 1703-1719.
    1. Durham BH, Lopez Rodrigo E, Picarsic J et al. Activating mutations in CSF1R and additional receptor tyrosine kinases in histiocytic neoplasms. Nat. Med. 2019; 25; 1839-1842.
    1. Kemps PG, Picarsic J, Durham BH et al. ALK-positive histiocytosis: a new clinicopathologic spectrum highlighting neurologic involvement and responses to ALK inhibition. Blood 2022; 139; 256-280.
    1. Kemps PG, Zondag TCE, Arnardóttir HB et al. Clinicogenomic associations in childhood Langerhans cell histiocytosis: an international cohort study. Blood Adv. 2023; 7; 664-679.

LinkOut - more resources